CDK12‐inactivation‐induced MYC signaling causes dependency on the splicing kinase SRPK1
Inactivation of cyclin‐dependent kinase 12 (CDK12) characterizes an aggressive sub‐group of castration‐resistant prostate cancer (CRPC). Hyper‐activation of MYC transcription factor is sufficient to confer the CRPC phenotype. Here, we show that loss of CDK12 promotes MYC activity, which renders the...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-10-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13666 |